NF-κB inhibition delays DNA damage-induced senescence and aging in mice.


The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-κB drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-κB in WT and progeroid model mice. As both WT and progeroid mice aged, NF-κB was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-κB or treatment with a pharmacological inhibitor of the NF-κB-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-κB reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-κB activation. IKK/NF-κB inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.

DOI: 10.1172/JCI45785

9 Figures and Tables

Citations per Year

225 Citations

Semantic Scholar estimates that this publication has 225 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tilstra2012NFBID, title={NF-κB inhibition delays DNA damage-induced senescence and aging in mice.}, author={Jeremy S. Tilstra and Andria Rasile Robinson and Jin Wang and Siobh{\'a}n Q Gregg and Cheryl L. Clauson and Daniel P Reay and Luigi Aurelio Nasto and Claudette M. St Croix and Arvydas Ūsas and Nam Viet Vo and Johnny Huard and Paula R. Clemens and Donna B Stolz and Denis C . Guttridge and Simon C Watkins and George A Garinis and Yinsheng Wang and Laura J. Niedernhofer and Paul D . Robbins}, journal={The Journal of clinical investigation}, year={2012}, volume={122 7}, pages={2601-12} }